LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
Hs 578T	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	929	3040	3228	0.9417	0.9182
Hs 578T	AZD8055	0.04	uM	LJP6	2	A12	72	hr	929	1419	3228	0.4396	0.2131
Hs 578T	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	929	2307	3228	0.7147	0.5993
Hs 578T	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	929	2824	3228	0.8748	0.8242
Hs 578T	AZD7762	0.04	uM	LJP6	1	L06	72	hr	929	1738	3228	0.5384	0.3518
Hs 578T	AZD8055	0.04	uM	LJP6	1	A12	72	hr	929	1471	3228	0.4557	0.2357
Hs 578T	Afatinib	0.04	uM	LJP6	3	G24	72	hr	929	3122	3228	0.9671	0.9539
Hs 578T	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	929	3103	3228	0.9613	0.9456
Hs 578T	AT-7519	0.04	uM	LJP6	1	K06	72	hr	929	3195	3228	0.9898	0.9856
Hs 578T	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	929	2977	3228	0.9222	0.8908
Hs 578T	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	929	3199	3228	0.9910	0.9874
Hs 578T	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	929	3019	3228	0.9352	0.9091
Hs 578T	AZD7762	0.04	uM	LJP6	2	L06	72	hr	929	1757	3228	0.5443	0.3601
Hs 578T	AZD7762	0.04	uM	LJP6	3	L06	72	hr	929	1798	3228	0.5570	0.3779
Hs 578T	Afatinib	0.04	uM	LJP6	1	G24	72	hr	929	3002	3228	0.9300	0.9017
Hs 578T	Afatinib	0.04	uM	LJP6	2	G24	72	hr	929	3085	3228	0.9557	0.9378
Hs 578T	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	929	3126	3228	0.9684	0.9556
Hs 578T	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	929	3283	3228	1.0170	1.0239
Hs 578T	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	929	2269	3228	0.7029	0.5828
Hs 578T	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	929	2160	3228	0.6691	0.5354
Hs 578T	AT-7519	0.04	uM	LJP6	2	K06	72	hr	929	3114	3228	0.9647	0.9504
Hs 578T	AT-7519	0.04	uM	LJP6	3	K06	72	hr	929	3291	3228	1.0195	1.0274
Hs 578T	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	929	2974	3228	0.9213	0.8895
Hs 578T	AZD8330	0.04	uM	LJP5	1	G24	72	hr	929	1457	3228	0.4514	0.2296
Hs 578T	AZD8055	0.04	uM	LJP6	3	A12	72	hr	929	1483	3228	0.4594	0.2409

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)